The National Company Law Tribunal (NCLT) Bangalore Bench has ordered the liquidation of a debt-ridden company, M/s. Vivimed Labs Ltd., after it failed to repay its debts. Background: Vivimed Labs Ltd. was a pharmaceutical company that had been facing financial difficulties for several years. The company had outstanding debts of over Rs. 1,000 crores and had failed to repay its creditors. Parties: The petition was filed by the company's creditor, M/s. Axis Bank Ltd. Legal issues: The main issue before the NCLT was whether the company was eligible for liquidation under the Insolvency and Bankruptcy Code (IBC). Court observations: The NCLT observed that the company had failed to provide any viable plan for repayment of its debts and that liquidation was the only viable option. Significance: The order highlights the strict approach of the NCLT towards companies that fail to repay their debts and the importance of the IBC in resolving insolvency cases. The liquidation of Vivimed Labs Ltd. is expected to have significant implications for the pharmaceutical industry in India.